Antimicrobial susceptibility testing with EUCAST methods and breakpoints
09 July 2021
3. Bacterial susceptibility & resistance, 2,5-hour Educational Workshop
3c. Susceptibility testing methods (incl assay validation and comparative studies, excl TB)
•
2166
•
08:30
>
11:00
•
Antimicrobial susceptibility testing with EUCAST methods and breakpoints
•
3. Antimicrobial resistance
3c. Susceptibility testing methods (incl assay validation and comparative studies, excl TB)
08:30
•
2166-1
•
EUCAST Update
>
C.
Christian
GISKE (Stockholm)
08:45
•
2166-2
•
Susceptible: increased exposure and area of technical uncertainty: the story so far
>
G.
Gunnar
KAHLMETER (Växjö)
09:00
•
2166-3
•
Aminoglycosides revisited
>
S.
Shampa
DAS (Liverpool)
09:15
•
2166-4
•
Piperacillin-tazobactam breakpoints in the wake of the Merino trial
>
A.
Alasdair
MACGOWAN (Bristol)
09:30
•
2166-5
•
Breakpoints for meningitis
>
C.
Christian
GISKE (Stockholm)
09:45
•
2166-6
•
Advances in mycobacterial AST
>
E.
Emmanuelle
CAMBAU (Paris)
10:00
•
2166-7
•
Antifungal susceptibility testing: update
>
M.
Maiken Cavling
ARENDRUP (Copenhagen)
10:15
•
2166-8
•
AST of <em>Stenotrophomonas</em> and <em>Burkholderia</em>
>
M.
Mandy
WOOTTON (Cardiff)
10:30
•
2166-9
•
Q&A/Discussion
|